[
  {
    "ts": "2026-01-08T21:30:00+00:00",
    "headline": "PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
    "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 2, 2026, the company approved 300 restricted stock units (\"RSUs\"), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee. The award was made pursuant to the Nasdaq inducement grant exception as a component of the new hire's employment compensation.",
    "url": "https://finance.yahoo.com/news/ptc-therapeutics-reports-inducement-grants-213000122.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "8b0a68a1-edac-3cd8-acb2-d7c26e738657",
      "content": {
        "id": "8b0a68a1-edac-3cd8-acb2-d7c26e738657",
        "contentType": "STORY",
        "title": "PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
        "description": "",
        "summary": "PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 2, 2026, the company approved 300 restricted stock units (\"RSUs\"), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee. The award was made pursuant to the Nasdaq inducement grant exception as a component of the new hire's employment compensation.",
        "pubDate": "2026-01-08T21:30:00Z",
        "displayTime": "2026-01-08T21:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63",
          "originalWidth": 400,
          "originalHeight": 244,
          "caption": "PTC Therapeutics, Inc. Logo (PRNewsfoto/PTC Therapeutics, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y8Qnhpz6m1dkuaR9LG7gIg--~B/aD0yNDQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63.cf.webp",
              "width": 400,
              "height": 244,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fMf2sn5IjgE8culMEnxjBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5c78d9ee565c8a63b9f458b2e6aeee63.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-reports-inducement-grants-213000122.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ptc-therapeutics-reports-inducement-grants-213000122.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTCT"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "PTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]